http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103361427-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103361427-B |
| titleOfInvention | MiRNA-219 compound is preparing the application in chronic pain diagnosis marker and medicine |
| abstract | The invention discloses miRNA-219 compound and prepare chronic pain disorders clinical diagnosis mark and the application in preparation treatment chronic pain medicine.The present invention is screened by great many of experiments, experimental result shows, miRNA-219 is down-regulated expression in chronic pain patient blood, chronic pain significantly can be suppressed to occur by raising miRNA-219 and formed, further quantitative analysis is carried out to the blood clinical sample of chronic pain patient, shown the mark that miRNA-219 can occur as chronic pain. |
| priorityDate | 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.